Citation Impact
Citing Papers
High-throughput characterization of protein–protein interactions by reprogramming yeast mating
2017 StandoutNobel
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
2015
Hierarchical design of pseudosymmetric protein nanocages
2024 StandoutNatureNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Applications of nanotechnology for immunology
2013
HLA-G, pre-eclampsia, immunity and vascular events
2003
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Ovarian cancer
2014 Standout
Nanoparticle Vaccines Against Infectious Diseases
2018
Delivery technologies for cancer immunotherapy
2019 Standout
Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA‐G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients
2004
Bioengineered protein-based nanocage for drug delivery
2016
Self-assembling protein nanoparticles in the design of vaccines
2015
Pre-eclampsia
2010 Standout
Biomaterials and emerging anticancer therapeutics: engineering the microenvironment
2015
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
2010 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
HLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
2003
Ovarian Tumorigenesis
2004
Food allergen immunotherapy: Current status and prospects for the future
2016
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management
2017 Standout
Non-Classical HLA-G Antigen and Its Role in the Cancer Progression
2006
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
Human Leukocyte Antigen-G5 Secretion by Human Mesenchymal Stem Cells Is Required to Suppress T Lymphocyte and Natural Killer Function and to Induce CD4+CD25highFOXP3+ Regulatory T Cells
2007 Standout
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Innate Lymphocyte Mechanisms in Skin Diseases
2020
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Translational nanoparticle engineering for cancer vaccines
2017
HLA-G gene repression is reversed by demethylation
2003
Beyond antigens and adjuvants: formulating future vaccines
2016
The potential of nanoparticles for the immunization against viral infections
2015
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
2017
Nanoparticles: Augmenting Tumor Antigen Presentation for Vaccine and Immunotherapy Treatments of Cancer
2017
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Calcium phosphates in biomedical applications: materials for the future?
2015 Standout
Immunology of Acute and Chronic Wound Healing
2021 Standout
Works of Joerg Willers being referenced
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma
2013
Nano‐particle vaccination combined with TLR ‐7 and ‐9 ligands triggers memory and effector CD 8+T ‐cell responses in melanoma patients
2012
HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas
2002